Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001562180-25-002904
Filing Date
2025-04-02
Accepted
2025-04-02 16:06:25
Documents
2
Period of Report
2025-04-01

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primarydocument.html 3  
1 PRIMARY DOCUMENT primarydocument.xml 3 14705
2 POWER OF ATTORNEY mquirkpoa.txt EX-24 1783
  Complete submission text file 0001562180-25-002904.txt   17921
Mailing Address 55 CAMBRIDGE PARKWAY CAMBRIDGE MA 02142
Business Address 55 CAMBRIDGE PARKWAY CAMBRIDGE MA 02142 617-299-8380
Sage Therapeutics, Inc. (Issuer) CIK: 0001597553 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O SAGE THERAPEUTICS, INC. 55 CAMBRIDGE PARKWAY CAMBRIDGE MA 02142
Business Address
Quirk Michael C. (Reporting) CIK: 0002063117 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36544 | Film No.: 25804386